# OnCo record avc-101 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/avc-101/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "avc-101" ;
  schema:name "AVC-101"@en ;
  schema:alternateName "UniCAR-T-CD123"@en ;
  schema:description "AVC-101 is an experimental autologous switchable CAR-T cell therapy from AvenCell Therapeutics, in phase 1 trials for relapsed or refractory acute myeloid leukaemia; its current status is not stated."@en ;
  schema:url <https://onco.cc/drugs/avc-101/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://avencell.com/avencell-raises-112-million-in-series-b-funding-led-by-novo-holdings/>, <https://avencell.com/avencell-to-present-new-data-from-universal-switchable-car-t-cell-therapy-programs-at-65th-american-society-of-hematology-annual-meeting-and-exposition/>, <https://clinicaltrials.gov/study/NCT04230265> ;
  onco:status "phase-1" ;
  onco:tag "pipeline" ;
  onco:modality "Autologous switchable CAR-T cell therapy (UniCAR, with separately dosed targeting module)" ;
  onco:targets <https://onco.cc/targets/cd123/> ;
  onco:companies <https://onco.cc/companies/avencell-therapeutics/> .